These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

921 related articles for article (PubMed ID: 32999081)

  • 1. Antimicrobial Peptide Exposure Selects for Resistant and Fit Stenotrophomonas maltophilia Mutants That Show Cross-Resistance to Antibiotics.
    Blanco P; Hjort K; Martínez JL; Andersson DI
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32999081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms and phenotypic consequences of acquisition of tigecycline resistance by Stenotrophomonas maltophilia.
    Blanco P; Corona F; Martinez JL
    J Antimicrob Chemother; 2019 Nov; 74(11):3221-3230. PubMed ID: 31369109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial Peptide Combination Can Hinder Resistance Evolution.
    Maron B; Rolff J; Friedman J; Hayouka Z
    Microbiol Spectr; 2022 Aug; 10(4):e0097322. PubMed ID: 35862981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of antimicrobial resistance in
    Gil-Gil T; Martínez JL; Blanco P
    Expert Rev Anti Infect Ther; 2020 Apr; 18(4):335-347. PubMed ID: 32052662
    [No Abstract]   [Full Text] [Related]  

  • 5. Involvement of the RND efflux pump transporter SmeH in the acquisition of resistance to ceftazidime in Stenotrophomonas maltophilia.
    Blanco P; Corona F; Martínez JL
    Sci Rep; 2019 Mar; 9(1):4917. PubMed ID: 30894628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review on
    Majumdar R; Karthikeyan H; Senthilnathan V; Sugumar S
    Recent Pat Biotechnol; 2022; 16(4):329-354. PubMed ID: 35549857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug-resistant Stenotrophomonas maltophilia: Description of new MLST profiles and resistance and virulence genes using whole-genome sequencing.
    Rizek CF; Jonas D; Garcia Paez JI; Rosa JF; Perdigão Neto LV; Martins RR; Moreno LZ; Rossi Junior A; Levin AS; Costa SF
    J Glob Antimicrob Resist; 2018 Dec; 15():212-214. PubMed ID: 30036694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of SmeGH contributes to the acquired MDR of Stenotrophomonas maltophilia.
    Li LH; Zhang MS; Wu CJ; Lin YT; Yang TC
    J Antimicrob Chemother; 2019 Aug; 74(8):2225-2229. PubMed ID: 31086945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of phage evolution and phage resistance in drug-resistant
    Han P; Lin W; Fan H; Tong Y
    J Virol; 2024 Feb; 98(2):e0124923. PubMed ID: 38189285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fosfomycin Resistance Evolutionary Pathways of
    Gil-Gil T; Martínez JL
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of multidrug resistant environmental isolates of
    Govender R; Amoah ID; Kumari S; Bux F; Stenström TA
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2021; 56(2):213-225. PubMed ID: 33378222
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms and consequences of bacterial resistance to antimicrobial peptides.
    Andersson DI; Hughes D; Kubicek-Sutherland JZ
    Drug Resist Updat; 2016 May; 26():43-57. PubMed ID: 27180309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?
    Zharkova MS; Orlov DS; Golubeva OY; Chakchir OB; Eliseev IE; Grinchuk TM; Shamova OV
    Front Cell Infect Microbiol; 2019; 9():128. PubMed ID: 31114762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stenotrophomonas maltophilia drug resistance.
    Sanchez MB; Hernandez A; Martinez JL
    Future Microbiol; 2009 Aug; 4(6):655-60. PubMed ID: 19659422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia.
    Pompilio A; Crocetta V; Scocchi M; Pomponio S; Di Vincenzo V; Mardirossian M; Gherardi G; Fiscarelli E; Dicuonzo G; Gennaro R; Di Bonaventura G
    BMC Microbiol; 2012 Jul; 12():145. PubMed ID: 22823964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interplay between intrinsic and acquired resistance to quinolones in Stenotrophomonas maltophilia.
    García-León G; Salgado F; Oliveros JC; Sánchez MB; Martínez JL
    Environ Microbiol; 2014 May; 16(5):1282-96. PubMed ID: 24447641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug-resistant Stenotrophomonas maltophilia in residential aged care facilities: An emerging threat.
    Sapula SA; Hart BJ; Siderius NL; Amsalu A; Blaikie JM; Venter H
    Microbiologyopen; 2024 Jun; 13(3):e1409. PubMed ID: 38682784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated evolutionary analysis reveals antimicrobial peptides with limited resistance.
    Spohn R; Daruka L; Lázár V; Martins A; Vidovics F; Grézal G; Méhi O; Kintses B; Számel M; Jangir PK; Csörgő B; Györkei Á; Bódi Z; Faragó A; Bodai L; Földesi I; Kata D; Maróti G; Pap B; Wirth R; Papp B; Pál C
    Nat Commun; 2019 Oct; 10(1):4538. PubMed ID: 31586049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial therapy for Stenotrophomonas maltophilia infections.
    Nicodemo AC; Paez JI
    Eur J Clin Microbiol Infect Dis; 2007 Apr; 26(4):229-37. PubMed ID: 17334747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system.
    Zhang L; Li XZ; Poole K
    Antimicrob Agents Chemother; 2000 Feb; 44(2):287-93. PubMed ID: 10639352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.